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DNA and histone methylation have been implicated
in epigenetic gene regulation. Recent studies in
Neurospora and now Arabidopsis indicate that
histone methylation can direct DNA methylation,
suggesting that these two methylation systems have
been functionally linked during evolution.
The epigenetically distinct alleles SUPERMAN and
clark kent of the model plant Arabidopsis provide a
paradigm for heritable changes in gene expression
that are not related to differences in the underlying
DNA sequence. Whereas the active SUPERMAN allele
remains unmethylated, the inactive clark kent allele
displays significant DNA methylation. What triggers
the transition between clark kent and SUPERMAN,
and how long can SUPERMAN maintain its ‘supernat-
ural’ powers? Jacobsen and colleagues [1] have
exploited the clark kent/SUPERMAN paradigm by
looking for mutations that reduce the stability of the
clk phenotype. Their new work has uncovered a
silencing pathway which places lysine methylation of
histone H3 upstream of DNA methylation, and involves
an HP1-like adaptor molecule that recruits the DNA
methyltransferase CMT3.
DNA methylation has long been regarded as a
mechanism for marking repressed genes, though its
causal importance in turning genes off has been con-
troversial. And while DNA methylation is widespread in
mammals, plants and some fungi [2], it is absent in
both budding and fission yeast and only sparsely
present in the nematode Caenorhabditis elegans and
the fruitfly Drosophila. Furthermore, whereas several
key enzymes for de novo and maintenance DNA
methylation have been characterized, the mechanisms
that direct and regulate DNA methylation remain
largely unknown [2,3].
Histone modifications have recently taken center
stage in epigenetic research, culminating in the
‘histone code’ hypothesis. The idea is that the modi-
fied histone tails provide binding sites for chromatin-
associated proteins, which in turn induce alterations in
chromatin structure and other downstream events
[4,5]. In particular, for silent chromatin domains,
histone H3 lysine 9 methylation by Su(var)3–9 family
histone methyltransferases has been shown to play a
key part in the formation of transcriptionally repressed
chromatin [6] by providing a high-affinity binding site
for the chromodomain of the heterochromatic HP1
proteins.
Can histone modifications talk to DNA methylation
and is there a functional relationship between the
two? Earlier work indicated that histone modifications
are downstream of DNA methylation, as components
of the DNA methylation machinery, such as the
methyl-CpG binding protein MeCP2 [7] and the DNA
methyltransferase Dnmt1 [8], were shown to recruit
histone deacetylases. But an important recent study
[9] in the fungus Neurospora crassa showed that
mutations in the gene decrease in DNA methylation
(dim5), which encodes what looks likely to be a
methyltransferase specific for histone H3 lysine 9,
result in almost complete loss of cytosine methylation
[9]. These data provided the first evidence that histone
methylation can trigger DNA methylation, although it
remained unresolved how histone H3 methylation
could recruit a DNA methyltransferase.
It is precisely this question which is addressed by
the new work of Jackson et al. [1] on SUPERMAN and
clark kent. Arabidopsis plants homozygous for the
clark kent allele show severe defects in floral archi-
tecture, notably an increase in the number of repro-
ductive organs, stamens and carpels. This phenotype
correlates with severely reduced expression of the
floral development gene SUPERMAN, which is con-
verted into the inactive ‘epiallele’ clark kent by cyto-
sine methylation, both symmetrically at CpGs and
CpXpGs and also at non-symmetrical sites [10]. 
To investigate the molecular mechanism for this epi-
genetic transition, Jacobsen and colleagues [1,11] per-
formed EMS mutagenesis in a non-revertible, clk-st
background, screening for progeny with a wild-type
floral phenotype. In total, 16 mutant alleles were recov-
ered which fell into three distinct classes. The first class
of nine mutations were mapped to a gene, CHRO-
MOMETHYLASE 3 (CMT3), which encodes a putative
DNA methyltransferase with a chromodomain [11].
CMT3 seems restricted to the plant kingdom and cmt3
mutations affect the genomic methylation pattern in a
very specific way. At all loci tested in the cmt3 mutant,
CpG methylation was found to be wild-type, but
CpXpG methylation was severely reduced. From these
data it can be concluded that silencing of the clark
kent epiallele mainly depends on CpXpG methylation.
The second class of three alleles were mapped to a
gene dubbed KRYPTONITE (KYP), which encodes a
protein with a SET domain, a hallmark motif of histone
methyltransferases [6,12]. Indeed, recombinant KYP
protein was found to have methyltransferase activity
specific for histone 3 lysine 9 [1]. Examination of the
DNA methylation profile in a kyp mutant background
revealed a defect in CpXpG methylation, remarkably
similar to what has been observed in cmt3 mutants
[1]. These data indicate that KYP-mediated histone H3
methylation can direct CpXpG methylation by CMT3,
but how does it recruit CMT3?
The most direct model would suggest that CMT3
binds to the histone H3 lysine 9-methylated termini
via its chromodomain. In vitro binding data, however,
indicated that CMT3 does not interact significantly
with H3 tails, methylated or not. Similarly, Suv39h
histone methyltransferases were found to associate
non-specifically with either unmodified or methylated
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histone tails, despite having chromodomains [13].
Selective recruitment of Suv39h histone methyltrans-
ferases requires interaction with the adaptor molecule
HP1, which mediates binding to methylated histone
tails [13–15]. Targeting of CMT3 seems to use the same
principle, as the Arabidopsis HP1 homologue LIKE
HETEROCHROMATIN PROTEIN 1 (LHP1) was shown to
bind with increased affinity to H3 lysine 9 methylated
tails, and to be able to interact with CMT3 [1]. 
The model suggested by these data (Figure 1) is
that KYP mediates histone H3 lysine 9 methylation in
the vicinity of the SUPERMAN locus, creating a
binding platform for LHP1. CMT3 is then recruited by
LHP1 and transforms SUPERMAN into clark kent by
catalysing cytosine methylation at CpXpG sites. Thus,
SUPERMAN is forced into wearing a ‘double disguise’,
in which both histone and DNA methylation cloak his
‘supernatural’ powers.
This mechanism implies that HP1 has a conserved
role as an adaptor molecule that reads the histone H3
lysine 9 methylation mark. But it also raises important
questions about the target specificity of other
chromodomains. Two recent papers [16,17] present
the structure of the HP1 chromodomain in a complex
with an H3 lysine 9 methylated peptide. The HP1
chromodomain structure, as described before [18],
consists of a three-stranded β sheet folded against a
carboxy-terminal α helix. The H3 peptide inserts into a
predicted groove in the HP1 structure, building a β
sheet by interaction with the flexible amino terminus
of the chromodomain (Figure 2A). 
Binding of the H3 peptide induces a shift in the HP1
structure, resulting in the formation of a cage which
depends on three aromatic side chains interacting
with the methyl group on lysine 9 (Figure 2B). The
complex structure reveals other important residues
involved in recognizing the amino-acid sequence
surrounding methylated lysine 9. Together, the data
allow predictions about which chromodomains may or
may not be able to bind to methylated lysine. But
whereas CMT3, Suv39h and LHP1 all fulfill the require-
ments to be methyl-lysine binders (Figure 2C), only
LHP1 displays enhanced affinity towards an H3 lysine
9 methylated peptide. By contrast, the related
chromodomains of the MOF and MSL proteins, com-
ponents of the Drosophila dosage-compensation
complex, lack the conserved residues required to bind
methylated lysine 9, and have been shown to associ-
ate with RNA [19]. There must be further determinants
of chromodomain binding specificity that we do not
yet know about.
Will there be a sequel to the timeless SUPERMAN
story, and how is KYP targeted to the SUPERMAN
locus? During development, there are likely to be fluc-
tuations in the SUPERMAN expression level. As low
transcriptional activity correlates with histone under-
acetylation, transcription-driven transitions in the
histone modification pattern of the SUPERMAN chro-
matin region might modulate substrate specificity for
the KYP histone methyltransferase, similar to what has
been proposed for ‘targeting’ of the Suv39h histone
methyltransferases [6]. Alternatively, we cannot
exclude the action of an unknown factor, and in this
respect the additional four alleles — the class 3
mutants — derived from the above mentioned EMS
screen might hold some surprises. 
Finally, when we leave the world of fungi and plants,
we should ask what can be learned of relevance for
mammalian systems? Although mammals apparently
lack homologs of CMT3, and their DNA methylation is
generally more complex (particularly for de novo DNA
methylation), it seems almost certain that a similar func-
tional link between histone and DNA methylation will
soon be established. Thus, mammalian ‘SUPERMEN’,
or related heroes, may also change their dress codes,
which are again likely to include several layers of
methylated accessories.
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Figure 1. SUPERMAN dresses up.
The silencing pathway that turns the active SUPERMAN locus
into its inactive epiallele clark kent. The pathway illustrated is
based on the findings reported recently by Jackson et al. [1]
(see text for details). Ac, acetyl; M, methyl.
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Figure 2. Chromodomain structure and
specificity.
(A) Structure of a free chromodomain
(magenta) overlaid with the structure of a
chromodomain (blue) bound to an H3
lysine 9 dimethylated peptide (yellow) [17].
(B) Structure of the methyl-binding aro-
matic cage containing trimethylated lysine
9 (Figure courtesy S. Khorasanizadel.)
(C) Alignment of the amino-acid
sequences of various chromodomains
(ClustalX 1.8). Residues important for H3
lysine 9 methyl-binding specificity are
highlighted: aromatic binding pocket, blue;
lysine 9 side chain specificity, purple;
binding of the key position alanine 7,
yellow. Arrows on top indicate the canoni-
cal chromodomain fold; red lines show
residues that interact with the β strand of
the H3 tail. Species abbreviations: Mm, M.
musculus; Dm, D. melanogaster; Sp, S.
pombe; At, A. thaliana (modified after [17]).
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Mm HP1α (19-72) EYVVEKVL------DRRMVK--GQVEYLLKWKGFSE-EHNTWEPEKNLD-CPELISEFMK-KYK
Mm HP1β (20-72) EYVVEKVL------DRRVVK--GKVEYLLKWKGFSD-EDNTWEPEENLD-CPDLIAEFLQ-SQK
Mm HP1γ (19-71) EFVVEKVL------DRRVVN--GKVEYFLKWKGFTD-ADNTWEPEENLD-CPELIEDFLN-SQK
Dm HP1 (23-75) EYAVEKII------DRRVRK--GKVEYYLKWKGYPE-TENTWEPENNLD-CQDLIQQYEA-SRK
Sp Swi6 (80-136) EYVVEKVL------KHRMARKGGGYEYLLKWEGYDDPSDNTWSSEADCSGCKQLIEAYWN-EHG
At LHP1 (107-160) FYEIEAIR------RKRVRK--GKVQYLIKWRGWPE-TANTWEPLENLQSIADVIDAFEG-SLK
At CMT3 (381-441) VFTVDKIVGISFGVPKKLLK--RGLYLKVRWLNYDD-SHDTWEPIEGLSNCRGKIGEFVKLGYK
Mm Suv39h1 (42-94)  DFEVEYLC------DYKKIR--EQEYYLVKWRGYPD-SENTWEPRQNLK-CIRVLKQFHK-DLE
Mm Suv39h2 (117-169) NYEVEYLC------DYKVAK--GVEYYLVKWKGWPD-STNTWEPLRNLR-CPQLLRQFSD-DKK
Dm MOF (392-449) VHRGQVLQ------SRTTENAAAPDEYYVHYVGLNR-RLDGWVGRHRISDNADDLGGITVLPAP
Dm MSL3 (451-504) FLNASPIS------NKKLED---LLPHLDAFINYLE-NHREWFDRENFVNSTALPQEDLQRELL
A
C
B
β1 β2 β3 α
